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Abstract The dipeptide carnosine (~-alanyl-L-histidine) was 
readily glycosylated non-enzymatically upon incubation with the 
sugars glucose, galactose, deoxyribose and the triose dihydroxy- 
acetone. Carnosine inhibited glycation of actyl-Lys-His-amide by 
dihydroxyacetone and it protected c~-crystallin, superoxide dis- 
mutase and catalise against glycation and cross-linking mediated 
by ribose, deoxyribose, dihydroxyacetone, dihydroxyacetone 
phosphate and fructose. Unlike certain glycated amino acids, 
glycated carnosine was non-mutagenic. The potential biological 
and therapeutic significance of these observations are discussed. 
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levels are elevated, e.g. diabetes [9,10] and can result in abnor- 
malities of connective tissue, e.g. collagen cross-linking [11]. 
Analysis of the preferred glycation sites in proteins shows 
that the e-amino groups of lysine residues are primary targets, 
particularly when in proximity to histidine residues [12]. In a 
search for stable peptides with long half-lives we found that the 
amino acid sequence of carnosine is similar to Lys-His, thus 
having the potential to react with sugars. In this communica- 
tion we describe the non-enzymatic glycosylation of carnosine 
and demonstrate its protective action against protein cross- 
linking. 
Materials and methods 
1. Introduction 
Carnosine, a naturally-occurring dipeptide (fl-alanyl-L-his- 
tidine) first described in 1900 by Gulewitsch and Amiradzibi [1], 
is found predominantly in post-mitotic tissues (e.g. brain and 
innervated muscle) of vertebrates. The dipeptide is present in 
millimolar concentration most likely because of its resistance 
to cleavage by intracellular proteases and the low activity of 
specific carnosinases [2]. The biological role of carnosine re- 
mains unclear but homeostatic or protective functions have 
been proposed. The high carnosine concentration found in tis- 
sues has a buffering effect at physiological pH [6]. Carnosine 
is also claimed to decrease oxygen free-radical mediated am- 
age to cellular macromolecules ither by chelating divalent cat- 
ions [3] or scavenging hydroxy radicals with its imidazole moi- 
ety [4,5]. Free-radical damage is not the only process to affect 
the structure of proteins and nucleic acids however. Non-enzy- 
matic glycosylation (glycation), the Maillard reaction in food 
chemistry [7], involves reaction of amino groups with sugar 
aldehyde or keto groups to provoke, eventually, cross-linking 
and advanced glycosylation and products (AGE-products) [8]. 
Although glycation is slow in vivo, it is of fundamental impor- 
tance in ageing and in pathological conditions where sugar 
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Peptides were synthesised by Peptide Technology Ltd., Dee Why, 
NSW, Australia. All other specialist chemicals and proteins were from 
Sigma Chemical Co., St. Louis, MO, USA. 
Unless otherwise stated, the reaction between peptides and amino 
acid derivatives with sugars was carried out in phosphate buffered 
saline, PBS (150 mM NaC1, 10 mM sodium phosphate, pH 7.4) in 
sealed microcentrifugation vials at 60°C and contained 50 mM peptide 
and 500 mM sugar. At specified times, samples were withdrawn, diluted 
1:20 with water and stored at -20°C prior to analysis by HPLC. The 
reaction between proteins and sugars was carried out at 37°C in sealed 
microcentrifuge tubes in 100 mM sodium phosphate buffer pH 7.0 with 
sodium azide added (0.01%) to prevent microbial growth. 
The detection of free amino groups on peptides was performed using 
a Waters AUTO.OPA system (Waters AUTO.TAG operation man- 
ual). In brief, peptides were reacted with o-phthalaldehyde and the 
fluorescent derivate separated by HPLC on a Radical-PAK C~8 column 
using a 10% (v/v) to 90% (v/v) methanol gradient as solvent over 15 min. 
A Waters 470 fluorescence detector set at excitation 340 nm/emission 
440 nm was used. 
Electrophoresis of proteins (SDS PAGE) was performed by using 
4-15% gradient polyacrylamide 'Ready Gels' (Bio-Rad Laboratories, 
Hercules, CA, USA) according to manufacturer's instructions. Gels 
were stained with Coomassie blue [13]. 
The analysis of mutagenic potential of glycated compounds was 
performed according to Kim et al. [14]. In brief, D-glucose (1 M) and 
each of the following: L-carnosine, L-lysine, L-alanine (all 1 M) were 
dissolved in distilled water, the pH adjusted to 7 and the mixtures 
heated at 100°C for 80 min. The solutions (50/zl and 100 ,ul) were 
evaluated against strain TA 100 of Salmonella typhimurium using the 
plate incorporation method [15] with or without metabolic activation 
by a standard rat liver microsomal (S-9) preparation. 2-AF and 2-AAF 
were used as positive controls for the experiments with metabolic stim- 
ulation, otherwise sodium azide was included as strain specific positive 
control. 
The spectra of solutions of peptides, amino acids and sugars were 
obtained using a Cecil C500 spectrophotometer. 
Abbreviations: Ac-, acetyl-; 2AF, 2-aminofluorene; 2AAF, 2-acetami- 
dofluorene; AGE-products, advanced glycosylation end-products; 
DAHP, dihydroxyacetone phosphate; DHA, dihydroxyacetone; PBS, 
phosphate-buffered saline (150 mM NaC1, 10 mM sodium phosphate, 
pH 7.4). 
3. Results 
Spectrophotometric and HPLC analyses provided evidence 
that carnosine readily reacts with sugars. The non-enzymic 
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Fig. 1. The effects of incubating carnosine or lysine with deoxyribose 
or glucose on u.v. absorption. Incubations were carried out in 50 mM 
sodium phosphate buffer pH 7.0 for 1 or 4 days: concentration of all 
reactants was 20 mM. (a) lysine + deoxyribose; (b) lysine + glucose; (c) 
carnosine + deoxyribose; (d) carnosine + glucose. 
reaction with proteins, peptides and amino acids with sugars 
has been extensively studied. The accepted route initially in- 
volves the production of a Schiff's base, followed by an Ama- 
dori rearrangement and eventually formation of advanced gly- 
cosylation end-products (AGE-products) which are frequently 
brown and cross-linked [7,16]. While the chemistry of these 
reactions i  complex and incompletely characterized, initial ev- 
idence for glycation is a change in the u.v. spectrum of the 
reaction mixture. Typically an increase in absorbance ataround 
280 nm is detected followed by a smaller increase at around 320 
nm wavelength [17]. It is known that lysine is readily glycatable 
[12,14,17] and Fig. 1 shows the spectral changes that occur 
following incubation with glucose or deoxyribose. Fig. 1 also 
shows that carnosine produces imilar, though not identical, 
spectral changes, especially the absorbance peak at around 280 
nm. Table 1 shows that both carnosine and lysine produced 
yellow/brown solutions following prolonged incubations with 
a glucose concentration i  excess of 1 M. In these experiments 
unphysiological (for mesophiles) temperatures and sugar con- 
centrations were employed to increase reaction rates. 
The reaction of carnosine with sugars was also studied by 
following its disappearance using fluorescence HPLC; the fluo- 
rescent agent reacted with amino groups. After 5 h incubation 
0.7, 3.6 and 11.9% of the carnosine (initially at 60 mM) had 
reacted with glucose, galactose and dihydroxyacetone (DHA) 
(all at 180 mM), respectively, which was in the expected increas- 
ing order. Again unphysiological temperatures (60°C) and 
sugar concentrations were employed for expediency of experi- 
mentation. Preferred glycation sites in proteins are amino 
groups in the vicinity of imidazole functions and/or carboxyl 
groups [12] e.g. lysyl-histidinyl dipeptides sequences. The 
dipeptide :z-acetyl-lysyl-histidine amide (i.e. with ~ amino and 
carboxyl groups blocked as would be the case with Lys-His 
dipeptide sequences present in a protein) (at 40 mM) was read- 
ily glycatable as revealed by the disappearance of its amino 
group with 16% of it reacting with DHA (80 mM) in 5 h at 
60°C. When the two dipeptides (both at 40 mM) were mixed 
and incubated together with DHA (80 mM), only 4% of the 
acetyl-Lys-His-amide reacted presumably because of the pre- 
ferred glycation of carnosine. The dipeptide fl-alanyl-glycine 
was less protective towards acetyl-Lys-His-amide as 11% of the 
latter eacted in 5 h when these peptides (both at 40 mM) were 
incubated together with DHA (80 mM). Again elevated temper- 
atures and unphysiological sugar concentrations were em- 
ployed. 
Suger-mediated protein glycation produces cross-linked 
products as revealed by SDS PAGE by the production of slowly 
migrating bands. Fig. 2 shows that incubation of c~-crystallin 
with ribose or deoxyribose generates more slowly migrating 
species i.e. of higher molecular weight, but the additional pres- 
ence of carnosine inhibited production of the higher molecular 
weight species in a concentration-dependent manner. Lane 3 
(Fig. 2) shows that incubation of the protein with deoxyribose 
produced a broad band of material which either remained at 
the top of the gel or migrated very little, and additionally more 
distinct bands which corresponded toproteins of apparent mo- 
lecular weights ome 3- or 4-times that of the original polypep- 
tide (21,000 Da). Lane 4 shows that 10 mM carnosine de- 
creased production of the very highest molecualr weight mate- 
rial with a corresponding increase in protein of molecular 
weight around 60,000 Da. Lane 5 shows that 50 mM carnosine 
prevented the generation of cross-linked crystallin. Lanes 6 and 
7 show the effects of incubation of crystallin with ribose for 6 
and 9 days, respectively, by the generation of higher molecular 
weight material especially in lane 7 (9 days). Lanes 8 and 9 
clearly show that carnosine prevents the production of the 
cross-linked protein. 
Table 1 
Effect of incubating carnosine and amino acids with glucose on u.v. 
absorption 
Absorption at 400 nM 
Glucose 0.175 
Glucose + carnosine 8.455 
Carnosine 0.041 
Glucose + fl-alanine 1.240 
Glucose + L-lysine 4.170 
Glucose + L-arginine 0.469 
Incubations carried out in 50 mM sodium phosphate buffer pH 7.0 for 
18 h at 50°C. Carnosine and amino acid concentrations u ed were 500 
mM, and glucose mployed at 1.39 M. 
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were decreased to 10 mM or less in the experiments with pro- 
teins, again to improve the physiological appropriateness of
these experiments; this necessitated experiments of 2 to 9 days 
duration. However, protection against sugar-mediated cross- 
linking using much higher sugar concentrations was again me- 
diated by carnosine (not shown) which affirms the efficacy of 
the dipeptide as a potential anti-cross-linking a ent. 
Glycated amino acids such as lysine and arginine are mut- 
(a) 1 2 3 4 5 
Fig. 2. Inhibition of ribose or deoxyribose-mediated cross-linking of 
~-crystallin by carnosine. Bovine ~-crystallin (100 Bg/ml) was incubated 
in 100 mM sodium phosphate buffer pH 7.0 with 10 mM ribose or 
deoxyribose with or without carnosine (10-50 mM) at 37°C for 9 days 
(6 days for lane 6). Lane 1, crystallin; lane 2, crystallin + 25 mM car- 
nosine; lane 3, crystallin + deoxyribose; lane 4, crystallin + deoxyribose 
+ 10 mM carnosine; lane 5, crystallin + deoxyribose + 50 mM carnos- 
ine; lane 6, crystallin + ribose (6 days incubation); lane 7, crystallin + 
ribose; lane 8, crystallin + ribose + 10 mM carnosine; lane 9, crystallin 
+ ribose + 25 mM carnosine; lane 10, marker proteins. 
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Fig. 3a shows that carnosine protected a-crystallin against 
cross-linking induced by the highly reactive dihydroxyacetone 
phosphate (DHAP). Here (lane 2) incubation for 2 days with 
1 mM DHAP produces cross-linked crystaUin of molecular 
weights 40,000 and 60,000 Da corresponding to dimers and 
trimers of the original protein. However, carnosine at 100 mM 
prevented the generation of the cross-linked protein (lane 4). 
Fig. 3b illustrates the effect of dihydroxyacetone on superoxide 
dismutase. Lane 3 shows that the triose induces the production 
of a rather broad band of material of molecular weight around 
45,000 Da approximating to the generation of cross-linked 
dimers of the protein. Both 25 and 50 mM carnosine prevented 
the production of the cross-linked polypeptide (lanes 4 and 5, 
respectively). Fig. 3c shows the effect of fructose on catalase 
(lane 3) and that carnosine can prevent production of the cross- 
linked protein (lanes 4 and 5). It should be pointed out that in 
all experiments carried out using proteins, a temperature of 
37°C rather than 50°C or 60°C (as used with lysine and the 
dipeptides) was employed to decrease the possibility of heat- 
induced protein denaturation; protection against sugar- medi- 
ated protein cross-linking by carnosine also occurred at 50°C 
however (not shown). Additionally the sugar concentrations 
Fig. 3. Inhibition of protein glycation by carnosine. (a) Bovine a- 
crystallin (100 ~tg/ml) was incubated in 100 mM sodium phosphate 
buffer pH 7.0 with 1 mM dihydroxyacetone-phosphate (DHAP) for 2 
days at 37°C. Lane 1, crystallin; lane 2, crystallin + DHAP; lane 3, 
crystallin + DHAP + 10 mM carnosine; lane 4, crystallin + DHAP + 
100 mM carnosine; lane 5, marker proteins. (b) Bovine superoxide 
dismutase (SOD) (100/tg/ml) was incubated in 100 mM sodium phos- 
phate buffer pH 7.0 with 10 mM dihydroxyacetone (DHA) for 2 days 
at 37°C. Lane 1, SOD; lane 2, SOD + 25 mM carnosine; lane 3, SOD 
+ DHA; lane 4, SOD + DHA + 25 mM carnosine; lane 5, SOD + DHA 
+ 50 mM carnosine. (c) Bovine catalase (CAT) (100/tg/ml) was incu- 
bated in 100 mM sodium phosphate buffer pH 7.0 with 10 mM fructose 
for 7 days at 37°C. Lane 1, CAT; lane 2, CAT + 25 mM carnosine; lane 
3, CAT + fructose; lane 4, CAT + fructose + 50 mM carnosine; lane 
5, CAT + fructose + 100 mM carnosine; lane 6, marker proteins. 
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Table 2 
Mutagenic potential of glycated compounds 
Compound Dose (1) Revertants 
per plate with 
TA 100 
without S-9 with S-9 
L-carnosine 250 158 + 11 149 + 13 
50 154 _+ 14 179 + 15 
L-carnosine glycated 250 142 +_ 17 158 + 19 
50 159 + 7 167 _+ 10 
L-lysine glycated 250 277 _+ 21 244 + 13 
50 357 + 17 553 +_ 19 
L-alanine glycated 250 145 + 6 146 +_ 9 
50 160 + 9 181 +_ 10 
negative control 161 +_ 6 188 _+ 10 
+ azide > 1000 N/A 
+ 2AF N/A 250 + 33 
+ 2AAF N/A >500 
Salmonella typhimurium TA 100 indicator strain his to his + reversion 
system. Data represent the mean number of revertants per plate and 
their standard eviation for the test solutions and controls with and 
without metabolic stimulation by rat liver microsomal (S-9) prepara- 
tion. 
agenic [14] as judged by the 'Ames Test' [15]. Other glycated 
amino acids, such as proline and cysteine, do not exhibit mut- 
agenicity [14]. We investigated the mutagenicity of L-carnosine 
and the glycated forms of L-carnosine, L-lysine and L-alanine 
(Table 2). Our data confirm the results of Kim et al. [14] that 
glycated L-lysine is mutagenic and may therefore be carcino- 
genic. The activity is slightly enhanced by the rat liver S-9 
metabolic activation system. Glycated L-alanine showed no 
mutagenicity in our experiments and only weak mutagenicity 
in the earlier work [14]. Both free carnosine and glycated car- 
nosine were not mutagenic. The reason for the difference of the 
glycated forms of L-carnosine and L-lysine is not known. 
4. Discussion 
Carnosine has been suggested to have a variety of functions 
in vitro. Examples are free radical scavenging activity [4,5], 
chelation of divalent cations [3] and good buffer capacity at 
neutral pH [6]. The results described in this paper point to the 
possibility that carnosine has another property. Our results 
indicate that the dipeptide reacts rapidly with reducing sugars 
and that the reaction rate is comparable to the lysine-histidine 
sequence preferentially glycated in proteins in vivo. The struc- 
tural similarities between carnosine and this amino acid se- 
quence, the dipeptide's ability to decrease glycation of the 
model peptide Ac-Lys-His-NHz, and the apparent inhibition of 
sugar-mediated cross-linking of bovine c~-crystallin, superoxide 
dismutase and catalase by carnosine in vitro would indicate that 
the dipeptide could possibly play a similar role in vivo. Both 
superoxide dismutase and catalase are components of the de- 
fense system against oxygen free-radicals and may be important 
in controlling ageing and its related pathologies. That carnosine 
is associated with neurones which are normally totally depend- 
ent on glucose and long-lived is consistent with an anti-ageing 
role. If carnosine were to be glycated in vivo, the resultant 
non-mutagenic product would also be consistent with homeo- 
static functions which preserve protein integrity and decrease 
the yield of endogenously generated mutagenic agents (i.e. gly- 
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cated amino acids) upon proteolysis of glycated proteins. How- 
ever, glycated forms of carnosine of biological origin have yet 
to be reported. The finding of N-carboxymethyllysine, a degra- 
dation product of Amadori compounds, in urine [19], and car- 
nosine's tructural similarity to preferred glycation sites in pro- 
teins suggests that such a search should be undertaken. 
Brownlee t al. [20] and Ceriello et al. [21] have observed that 
glycation of anti-thrombin III (AT-III) interfered with its inhib- 
itory activity towards thrombin and suggested that it is the 
labile Schiff base adduct o AT-III which decreases its activity 
during hyperglycaemia. Interestingly, we have observed that 
carnosine can prevent formation of cross-linked AT-III in 
model studies (not shown). Similar protective ffects by camos- 
ine have also been found when LDL, apoB, fibronectin and 
laminin were used as target proteins (not shown). The potential 
anti-glycating property of carnosine suggests that the dipeptide 
could be considered in treatment of diabetics where glycation 
is the initial step leading towards important pathological sec- 
ondary effects. Homocarnosine (y-amino-butyryl-L-histidine) 
showed a lower reactivity than carnosine and indicates that 
minor structural changes influence glycation rates. This may 
permit he design of carnosine analogues which have different 
reactivities at selected steps in the glycation process and, to- 
gether with carnosine, be used as tools for future studies. In 
vitro glycation of tripeptides has been described [22] but their 
susceptibility owards peptidases in vivo restricts their potential 
usefulness. In contrast, carnosine, a fl-peptide, is not readily 
attacked by non-specific peptidases. 
The different glycation rates of carnosine by glycose, galac- 
tose and dihydroxyacetone w  observed reflect the reported 
differences in sugar reactivities [23]. We have also shown that 
the fast-reacting sugar, 2-deoxy-l>ribose can glycate carnosine 
and lysine. We speculate that carnosine could preferentially 
react with the C1 of deoxyribose at apurinic sites in DNA, 
thereby sparing formation of cross-links between ucleopro- 
teins and DNA as well as perhaps facilitating excision repair 
of the modified DNA. Preliminary studies indicate that carnos- 
ine can inhibit DNA/protein cross-linking in model systems 
(Hipkiss and Farnaud, unpublished). Consistent with this pro- 
posal are the observations that carnosine can prevent chromo- 
somal aberrations in Chinese Hamster ovary cells [24] and 
radiolabelled carnosine is found associated with single stranded 
DNA fragments following ultraviolet irradiation of human fi- 
broblast in the presence of [14C]carnosine (Hipkiss and Holli- 
day, unpublished observation). Furthermore, the observation 
that carnosine can delay senescence in cultured human fibro- 
blasts [25] reinforces the proposal that carnosine, usually asso- 
ciated with long-lived cells (i.e. neurones) may possess useful 
protective properties against he deleterious side effects of glu- 
cose, other sugars and oxygen. Furthermore the possibility of 
an association between glycation and Alzheimer's Disease [26] 
immediately suggests that the potential use of anti-glycators 
such as carnosine should be explored. 
Acknowledgements: We are grateful to Mr. Methsiri Edirisinghe and 
Ms. Yen Lain for excellent technical assistance, and to Pharmaceutical 
Consulting Service, NSW, Australia, for help with the mutagenicity 
tests. We thank the World Cancer Research Fund for support, the 
Royal Society for the award of a travel grant o A.R.H. and gratefully 
acknowledge the hospitality and encouragement of Dr. Robin Holliday 
(FRS) and his colleagues at CSIRO Molecular Biology Laboratories, 
North Ryde, Sydney, Australia. 
A.R. Hipkiss et al./FEBS Letters 371 (1995) 81-85 85 
References 
[1] Gulewitsch, W. and Amiradzibi, S. (1900) Ber. Dtsch. Chem. Ges. 
33, 1902 1903. 
[2] Bando, K., Shimotsuji, T., Toyoshima, H. and Hayashi, C. (1984) 
Ann. Clin. Biochem. 21,510-514. 
[3] Viola, R.E., Hartzell, C.R. and Villafranca, J.J. (1979) J. Inorg. 
Chem. 10, 293-307. 
[4] Boldyrev, A.A., Dupin, A.M., Bunin, A.Y., Babizhaev, M.A. and 
Severin, S.E. (1987) Biochem. Intern. 15, 1105 1113. 
[5] Kohen, R., Yamamoto, Y., Cundy, K.C. and Ames, B. (1988) 
Proc. Natl. Acad. Sci. USA 85, 3175-3179. 
[6] Bate-Smith, E.C. (1938) J. Physiol. 93, 336-343. 
[7] Maillard, L.C. (1912) C.R. Acad. Sci. 154, 6(~68. 
[8] Baynes, J.W. and Monnier, V.M. (1989) The Maillard Reaction 
in Ageing, Diabetes and Nutrition; Progress in Clinical and Bio- 
logical Research, Vol. 304, Alan R. Liss, Inc. New York. 
[9] Trivelli, L.A., Ranney, H.M. and Hont-Tien, L. (1971) N. Engl. 
J. Med. 284, 353 357. 
[10] Cerami, A. and Koenig, R.J. (1978) Biochem. Sci. April, 73 
75. 
[11] Monnier, V.M., Vishwanath, V., Frank, K.E., Elmets, C.A., 
Dauchot, P. and Kohn, R.R. (1986) N. Engl. J. Med. 314, 403-408. 
[12] Shilton, B.H. and Walton, D.J. (1991) J. Biol. Chem. 266, 5587- 
5592. 
[13] Neuhoff, R., Stamm, H. and Elble, H. (1985) Electrophoresis 6, 
427-448. 
[14] Kim, S.B., Kim, I.S., Yeum, D.M. and Park, Y.H. (1991) Mut. 
Res. 254, 65-69. 
[15] Maron, D.M. and Ames, B.N. (1983) Mut. Res. 113, 173-215. 
[16] Ledl, F., Beck, J., Sengl, M., Osiander, H., Estendorfer, S., 
Severin, T. and Huber, B. (1989) in: The Maillard Reaction in 
Ageing, Diabetes, and Nutrition; Progress in Clinical and Biolog- 
ical Research (Baynes, J.W. and Monnier, V.M., eds.) Vol. 304, 
pp. 23-42, Alan R. Liss Inc., New York. 
[17] Pongor, S. (1984) Proc. Natl. Acad. Sci. USA 81, 2684-2688. 
[18] Shin, D.B., Hayase, F. and Kato, H. (1988) Agric. Biol. Chem. 52, 
1451-1458. 
[19] Ahmed, M.U., Thorpe, S.R. and Baynes, W.J. (1986) J. Biol. 
Chem. 26l, 4889-4894. 
[20] Brownlee, M., Vlassara, H. and Cerami, A. (1984) Diabetes 33, 
532-535. 
[21] Ceriello, A., Giugliano, D., Quatrato, A., Stante, A., Concoli, G., 
Dello Russo, P. and D'ONofrio, F. (1987) Diab. Metab. 13, 16-19. 
[22] Bai, Y., Ueno, H. and Manning, J.M. (1989) J. Prot. Chem. 8, 
299 315. 
[23] Monnier, VIM., Sell, D.R., Nagaraj, R.H, and Miyata, S. (1991) 
Gerontology 37, 152-165. 
[24] Gille, J.J.P., Pasman, P., van Berkel, C.G.M. and Joenje, H. (1991) 
Mutagenesis 6, 313-318. 
[25] McFarland, G.A. and Holliday, R. (1994) Expl. Cell Res. 212, 
167 175. 
[26] Yan, S.-D. (1994) Proc. Natl. Acad. Sci. 91, 7787-7791. 
